Plain-English translation of NCT06290063 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing hemp-derived cannabidiol (CBD), which is a compound from cannabis plants, to see if it can safely help older adults manage pain, anxiety, and sleep issues. You would take the medication daily for 8 weeks and be randomly assigned to receive either a full-spectrum version (with a small amount of THC, another cannabis compound), a broad-spectrum version (CBD only), or a placebo (inactive pill). The study aims to figure out which formulation works best and safest for older adults.
Cannabis use among adults over 65 has grown dramatically, but very little research exists on how safe these products are or how well they work for older people. This trial will help doctors and patients make better, more informed decisions about whether this medication is right for managing common problems like pain and anxiety in older age.
You likely qualify if…
You likely don't qualify if…
You would take a daily dose of the medication (or placebo) for 8 weeks. You'll be randomly assigned to one of three groups, so you won't know which type of medication you're receiving. Throughout the study, you'll be monitored to see how the medication affects your pain, anxiety, sleep, and overall well-being, and researchers will watch for any side effects or safety concerns.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States